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THE HARVEY LECTURES, SERIES 77 
THE MACROPHAGE-VERSATILE ELEMENT 
OF INFLAMMATION* 
ZANVIL A. COHN 
Laboratory of Cellular Physiology and Immunology, 
The Rockefeller University, 
New York, New York 
� URING the course of an inflammatory reaction, the system of 
1-.Anononuclear phagocytes is involved in multiple and complex 
tasks-from the initial signaling of other cellular elements to the de­
struction of local tissues and ultimately to tissue remodeling and wound 
repair. In this context they are also significant components of the nor­
mal physiological process of cellular turnover and degradation as well 
as diverse pathological events prominent in the chronic arthritides and 
atherosclerosis. 
To carry out these roles, bone marrow-derived cells must recognize, 
and emigrate to, the peripheral tissues. They must initiate the interior­
ization of environmental molecules of soluble and particulate nature and 
respond to other signals that turn on secretory cycles. In this discussion 
I review our current understanding of the mechanisms whereby this 
·versatile element of inflammation carries out both beneficial and de­
leterious tasks in mammalian hosts.
I. LIFE HISTORY: MAINTENANCE OF THE TISSUE COMPARTMENT
The nature of the pools and compartments of mononuclear pha­
gocytes represents information of relatively recent origin (van Furth and 
Cohn 1968; van Furth et al., 1972) and leads to the unitarian view that 
heterogeneous tissue pools all arise from common progenitors in the 
marrow (Fig. 1). Although our knowledge stems largely from small 
laboratory rodents, the fragments of available information suggest that 
similar kinetics obtain in man. Three facts distinguish their life history 
*Lecture delivered February 18, 1982. 
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FIG. I. Mononuclear phagocytes: pools and population (murine). 
from that of other blood-borne phagocytes. First, the bone marrow pool 
is relatively small, without significant storage of mature members of the 
series. Second, the cell is released into the circulation in a relatively 
immature form and matures or differentiates into a larger and more 
active macrophage while exposed to the environmental stimuli of the 
tissues. Finally, the life-span in the tissues is long, as the cell resides in 
a G
0 
state and may undergo repeated cycles of endocytic and secretory 
activity. It is likely that the macrophages in the perivascular connective 
tissue outlining small blood vessels have half-lives much longer than 
alveolar or Kupffer cells, which are constantly exposed to particulate 
agents. What should be emphasized, however, is the large tissue pool 
some 500-1000 times greater than the bone marrow compartment. Par­
enchymal organs such as liver are particularly rich sources, and mac­
rophages represent approximately 20-30% of the total cell number of 
this huge organ. Such long-lived macrophages of the tissue pool there­
fore represent a widely distributed in situ population poised, if you will, 
for an immediate response to perturbations by noxious stimuli-a popu­
lation that is soon joined by emigrating monocytes and younger ele­
ments of the marrow compartment that swell local numbers, in part by 
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replication. Under steady state conditions, monocytes leave the circula­
tion randomly, whereas they are selectively focused into areas of in­
flammation. In some instances, most of the daily production rate may 
enter an active lesion, leaving secondary sites relatively deficient in 
cells. This is also the result of the limited ability of the bone marrow 
(twofold) to increase its supply of cells by reducing the generation time 
and releasing more immature elements such as promonocytes. 
II. THE MIGRATORY EVENT 
The flight of monocytes from the circulation and their entry into the 
tissues occurs in a random fashion under steady state conditions and 
rather selectively during inflammation. It entails initial recognition of 
an endothelial cell surface, attachment, spreading, translational motility 
and directed movement or chemotaxis, basement membrane penetra­
tion, and fixation in the tissues. These multiple events are imperfectly 
understood and represent important regulatory steps in the inflammatory 
state. There are a number of products, however, that enhance the 
spreading of monocytes and macrophages (Bianco et al., 1976, 1979; 
Gotze et al., 1979) and may play a role in vivo. One of the best studied 
is the large split product of factor B of the alternative pathway of 
complement fixation. Factor Bb is a diisoprophyl fluorophosphate 
(DFP)-inhibitable serine esterase that, at microgram levels, rapidly 
spreads mononuclear phagocytes, inhibiting motility and in this sense 
representing a defined macrophage inhibitory factor (MIF). It is of 
interest that factor B is synthesized by macrophages and both secreted 
and placed on the surface of the plasma membrane. Since many of the 
spreading factors are proteinases (Rabinovitch and De Stefano, 1973), 
the cleavage of factor B on the macrophage surface may be the common 
denominator that controls attachment spreading and tissue localization. 
A second molecule that initiates the attachment of macrophage is 
fibronectin (Bevilacqua et al., 1981). Although macrophages, like 
many other cells, synthesize fibronectin, they have on their surface a 
receptor that recognizes this molecule. With the exposure of collagens 
and the subsequent binding of plasma fibronectin during tissue injury, 
the fibronectin receptor could play a significant role in many patholog­
ical states leading to macrophage accumulation and perhaps granuloma 
formation. 
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III. THE MACROPHAGE AS AN ENDOCYTIC CELL-THE V ACUOLAR 
APPARATUS 
The vacuolar apparatus of macrophages represents a particularly dy­
namic series of organelles comprising the plasma membrane, endo­
somes, and lysosomes. Considerable information has accrued over the 
years concerning the regulation and packaging of acid hydrolases (Cohn 
and Benson, 1965; Cohn et al., 1966). This information and the related 
studies on the initiation and maintenance of pinocytosis and pha­
gocytosis (reviewed in Silverstein et al., 1977) left us with knowledge 
of lysosomal contents--enzymes, substrates, and hydrolysis-but few 
insights into the membrane of the organelles and its composition, flux­
es, and turnover. 
Figure 2 and the accompanying expanded legend outlines in a sim-
4 





F1G. 2. Selected properties and dynamics of the vacuolar apparative of macrophages. 
I. Plasma membrane: a. Surface area of resident, mouse peritoneal cell = 825 µ,m2. b.
Total volume of resident, mouse peritoneal cell = 395 µ,m3. c. Fractional rate of internal­
ization as pinocytic vesicles = 3.1 % of total surface area per minute. d. Membrane in 
selectively labeled with soluble lactoperoxidase, 1251, glucose oxidase, glucose, method. 
e. There are approximately 24 exteriorly disposed, iodinatable glycoproteins. f. Labeled 
membrane proteins tum over synchronously with a half-life of± 25 hours. g. Monoclonal
antibodies recognize six distinctive membrane antigens. h. Both iodinatable polypeptides 
and antigens (g) cycle from cell surface, through the vacuolar apparatus, and back to cell 
surface as a unit. i. Endocytic receptors include two distinct FcRs, C3bR, and mannose R. 
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plified fashion the properties of the plasma membrane ( 1), pinocytic 
vesicles (2), phagocytic vacuoles (3), and secondary lysosomes (4). A 
more complete description can be found in a review (Cohn and Stein­
man, 1982). Figure 2 stresses our current information on the recycling 
and the reutilization of plasma membrane components as they flow from 
j. Membrane influx is inversely correlated with saturation of membrane phospholipid fatty 
acids. k. Arachidonic acid comprises 25% of total fatty acids. I. 5' -Nucleotidase and 
phosphodistinase I are useful ectoenzyme markers.
2. Pinocytosis and pinocytic vesicles: a. Both fluid-phase and adsorptive pinocytosis 
occur. b. Adsorptive vesicles exhibit clathrin coats. c. Average vesicle diameter = 0.202 
µ,m. d. Average vesicle surface area = 0.196 µ,m2. e. Average vesicle volume = 0.0143 
µ,m3. f. Percentage of total cell volume = 2.5%. g. Percentage of total surface area = 
12.5%. h. Steady state number per cell = 250-1000. i. Activation energy for generation 
= 18 kcal/mo!. j. Selectively labeling follows the fluid-phase uptake of an iodinating 
system. k. Polypeptide composition is indistinguishable from that of plasma membrane. I. 
Fluid phase vesicles are generated at a continuous and constant rate. m.· Vesicle fusion 
with lysosomes is selectively inhibited with tetravalent concanavalin A. n. Rate of genera­
tion is linear between 6 and 38°C. o. Increased saturation of fatty acids inhibits total 
vesicle formation without modifying activation energy. p. Pinocytosis is not inhibited 
with cytochalasin. q. It is focused into perinuclear zone by a saltatory flow mechanism. 
3. Phagocytosis and phagocytic vacuoles: a. Phagocytosis is a discontinuous and lo­
calized process. b. It is a receptor-mediated event-Fe , C3b, mannose. c. Vacuoles 
conform to size and shape of particles < I to > 10 µ,m. d. Internalization requires the 
circumferential flow of membrane, utilizing receptor-ligand interactions; ''zipper mecha­
nism." e. Activation energy is 45 kcal/mo!. f. Phagocytosis consumes high energy stores 
of creatine phosphate and ATP. g. Vacuoles are generated at temperatures only above 18 
± 2°C. h. Vacuoles are transiently associated with clathrin. i. Vacuole generation is 
inhibited with cytochalasin. j. Vacuoles fail to fuse with secondary lysosomes at tempera­
tures below 18 ± 2°C. k. Increased saturation of membrane phosphatide fatty acids 
decreases total particle internalization and elevates the activation energy for particle 
uptake. I. Polystyrene latex (I. I µ,m) phagocytic vacuoles contain a representative sample 
of plasma membrane polypeptides, antigens, and ectoenzymes. 
4. Phagolysosomes (secondary lysosomes): a. Secondary lysosomes (2° Lys.) may 
represent from 15 to 55% of the total cell surface area. b. Phagolysosomes are a fusion 
product of primary and secondary lysosomes with endosomes. c. Size depends upon both 
input of extracellular solutes and the rate of hydrolysis. d. Intravacuolar pH = 4. 7. e. 
Contain ± 30 hydrolytic enzymes with acid pH optima. f. Membranes are permeable to 
amino acids and selected dipeptides. g. Luminal surface of membrane is selectively 
labeled with lactoperoxidase-latex bead iodinating systems. h. Labeled polypeptides 
(iodinated) are indistinguishable from those of plasma membrane, phagocytic vacuole, 
and pinocytic vesicle. i. Centrifugal flow of polypeptides of plasma membrane occurs 
within 5 minutes of "recycling." j. Rapid and continuous contact with extracellular 
medium is via pinocytic vesicles. k. Storage of macroanions leads to a selective block in 
fusion with phagosomes but not pinosomes. 
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the cell surface through the cytosol and then return to the surface after 
delivering their contents to the digestive bodies or secondary lyso­
somes. The basis for this scheme can be found in a number of papers, 
which encompass stereological approaches,_ selective labeling of the 
vacuolar organelles, and turnover of intrinsic membrane glycoproteins. 
The initial information was derived from studies on the rate at which 
fluid phase and adsorbed solutes were interiorized within pinocytic 
vesicles (Steinman and Cohn, 1972a,b). These studies, at the biochemi­
cal and ultrastructural level, emphasized the rapidity of both solute 
interiorization and the rate of intralysosomal degradation. It was clear 
that molecules adsorbed to the plasma membrane Fe receptor were 
captured at rates 4 x 102 to 103-fold greater than the fluid phase 
reactants. Fluid phase uptake was a constant, constitutive nonsaturable 
event, whereas adsorptive endocytosis exhibited saturation kinetics and 
was discontinuous. It was not, however, until Steinman's careful ster­
eological analysis that we were aware of both the actual dimensions of 
the vacuolar system and the large quantity of membrane that was con­
tinually flowing into the cell (Steinman et al., 1976). During each 60 
seconds, 3.1 % of the total surface area of the macrophage (830 µm2) 
was entering the cytoplasm as vesicles or a total surface area each 33 
minutes. Since the individual plasma membrane polypeptides had half­
lives of 24-30 hours (Kaplan et al., 1979), one could discount any 
extensive digestion and synthesis to explain the results. A more likely 
possibility was that vesicle membrane was being reutilized and cycled 
back to the cell surface. We were assuming in some of these specula­
tions that a representative sample of polypeptides was present in the 
vesicles an_d were cycling in unison. This assumption wa� by no means 
clear and in fact had been challenged by a number of authors. 
A more definitive technique was required to follow the circuitry of a 
large group of plasma membrane polypeptides. This was accomplished 
utilizing the basic lactoperoxidase (LPO) iodination method developed 
by Hubbard and Cohn (1972). For this purpose, however, LPO was 
covalently coupled to carboxylated polystyrene latex beads via a water­
soluble carbodiimide, yielding a particle that could be rapidly estab­
lished within the secondary lysosome (Muller et al., 1980a,b). In the 
presence of glucose oxidase-generated hydrogen peroxide and iodide 
isotopes, rapid labeling occurred on the luminal surface of secondary 
lysosomes with only trace labeling of contents. This was carried out at 
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4°C, minimizing membrane movement and resulting in the lysosomal 
localization of radioactive grains on electron microscopic autoradiogra­
phy. As the temperature was raised to 37°C, a rapid flow of grains took 
place to the cell periphery, and at 30 minutes they were randomized on 
both the superior and inferior surfaces. 
Similar experiments were then carried out to label specifically either 
the exteriorly disposed surface of the plasma membrane or the newly 
formed pinocytic vesicles (Mell man et al., 1980). The polypeptide 
composition of each of the members of the vacuolar system were com­
pared, i.e., plasma membrane, pinosome, and secondary lysosome. On 
single-dimension, gradient SDS gels, approximately 24 iodinated poly­
peptides were easily discernible on each of the three organelles, and 
these were virtually indistinguishable. More recently Muller et al.
(1983) have compared the labeled plasma membrane and secondary 
lysosome on two-dimensional isoelectric focusing-SOS systems. Again 
no distinctions between the two membranes are apparent. Finally, ex­
amination of more "minor" membrane proteins detected with mono­
clonal antibodies indicates that the pinosome and secondary lysosome 
membrane are representative samples of the plasma membrane. In Fig. 
1, therefore, the flow or cycling process represents a membrane con­
tinuum. connected by means of extensive membrane fusions. 
The above synthesis of these results does not, however, preclude that 
receptor-mediated events could not lead to higher concentration of 
given polypeptides in the system. One such situation occurs with the 
Fen receptor of murine cells, which recognizes immune complexes. 
This receptor has been purified by Mellman and Unkeless (1980), and 
monoclonal and polyclonal antibodies were prepared against various 
epitopes expressed on both the exterior and cytoplasmic face of this 
transmembrane molecule. One antibody in particular recognizes the 
receptor on the macrophage surface even after its active site has been 
occupied (Mellman et al., 1983). This has allowed us to follow the 
internalization, cycling, and degradation of the receptor in the presence 
and in the absence of ligands of various valences. Turnover of the 
receptor was compared to four other exteriorly expressed unrelated 
antigens for which we had monoclonal probes. In the absence of an Fe 
ligand, each of the plasma membrane components had similar half-lives 
and expression in the vacuolar apparatus. However, in the presence of 
heavily opsonized erythrocyte ghosts about 50% of the Fe receptors 
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were occupied internalized, and cleared from the surface. Subse­
quently, both the receptor and ligand were rapidly digested-the recep­
tor demonstrating a half-life of only 2 hours under these conditions. In 
contrast, other membrane antigens retained their normal expression and 
turnover, which was more than 20 hours. Reexpression of the Fe recep­
tor was slow and in keeping with new synthesis. 
The focal ablation of a receptor from a cycling membrane system 
requires rather selective mechanisms. We believe that this does not take 
place at the plasma membrane by the generation of a coated vesicle of 
restricted composition. Certainly, the receptor may be clustered and 
enriched in this structure, but on a basal level of other membrane 
polypeptides. We think it more likely that selective degradation occurs 
within the secondary lysosomal compartment. Two possible mecha­
nisms are suggested in Fig. 3. Both are based upon the movement and 
clustering of the receptor in the plane of the membrane-a process that 
occurs with ease, as demonstrated by Silverstein and his colleagues. On 
the left, receptor aggregation leads to its local accumulation similar to 
the capping phenomenon in B lymphocytes. This in tum initiates the 
formation of an autophagic vacuole and a multi vesicular body, both of 
which are commonly encountered in macrophage cytoplasm (Hirsch et
al., 1968). The other mechanism would be shedding of the clustered 
Secondory Lysosome 
Aggregated receptor-ligand complex 
Autophogic / "-
vacuo� �. Introvocuolor / ,,"'.ll'�"· '\. coppin g 




Fie. 3. Mechanisms for the selective intracellular degradation of a receptor-ligand 
complex. 
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· receptor into the lumen and digestion. In both instances the receptor
would be selectively removed from the recycling pool of membrane.
IV. THE MACROPHAGE AS A MAJOR SECRETORY CELL 
Macrophages that enter the tissues or find themselves attached to the 
wall of sinusoids are long lived and maintain significant synthetic prop­
erties. Within the last decade our attention has been focused on the wide 
range of potentially important macromolecules that these cells release or 
secrete into their environment (Table I). Almost all these experiments 
have dealt with cultured cells, which are either exposed to a variety of 
stimuli or in different states of activation. 
One is immediately struck by the wide range and diversity of this list 
of products that may be employed in tissue injury, wound healing, and 
tissue remodeling (Nathan et al., 1980a,b). Some of my colleagues now 
refer to the macrophage as the "circulating hepatocyte." This analogy 
although somewhat facetious, nevertheless focuses on the importance of 
an emigrating, mobile population with this potential. 
Our initial studies on macrophage secretion dealt with what has 
turned out to be one of the two or three bulk secretory products, i.e., 
Iysozyme (Gordon et al., 1974). This enzyme is produced constitutively 
by most populations of mononuclear phagocytes. Many of the products 
are solely produced, or have their rate of secretion enhanced, under 
conditions of macrophage activation. This process, which is brought 
about both by nonspecific inflammatory environments as well as specif­
ic lymphoid products, has been reviewed (Cohn, 1978). Although our 
original concepts were biased toward enhancement of function, we now 
know, as outlined in Table II, that important molecules are lost or 
modulated. In particular, the striking depression in the levels of arach­
idonate metabolites, certain ectoenzymes, and plasma membrane anti­
gens are noteworthy. 
Many questions remain concerning the secretion of these products. 
What is the species variation in both qualitative and quantitative ex­
pression? What is their temporal sequence? Are there selective triggers, 
and can a cell return to a resting state to be stimulated in the future? 
Certainly these and other related queries are of concern in understanding 
the complexities of inflammation. 
TABLE I 
SECRETORY PRODUCTS OF MONONUCLEAR PHAGOCYTES THAT MODULATE THE 
INFLAMMATORY AND IMMUNE RESPONSES 
Complement components 
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a HMP, hexose monophosphate; PDE, phosphodiesterase; PGE, prostaglandin E; 
HETE, I 2L-hydroxy-5, I, I 0, 14-eicosatetranoic acid. 
V. THE MACROPHAGE AS AN EFFECTOR CELL 
A. The Intracellular Milieu
It was apparent from the earlier work of Rich, Lurie, and Danenberg, 
Suter and Mackaness and North, that the activation of macrophages 
during infection with intracellular microbial pathogens lead to an en­
hanced microbicidal state in the animal. This was followed by the 
elegant demonstrations of the important link between sensitized T cells, 
the production of lymphokines, and the activation of macrophages by 
Mackaness, North, David, and Bloom. Only more recently have we 
begun to understand the underlying mechanisms that lead to intra­
cytoplasmic killing and extracellular cytotoxic reactions. 
Our progress in this area was related to the availability of large, easily 
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scored targets that replicated only within living host cells. In addition, 
our ability to manipulate relatively homogeneous populations of resi­
dent, elicited, and activated cells under the defined conditions of an in 
vitro environment allowed us to approach biochemical distinctions. 
These methodological advances were aided by the extensive knowledge 
of n�utrophils, oxidases, the generation of oxygen intermediates and 
myeloperoxidase. This system, which lead to microbial halogenation or 
the "Klebanoff pathway," set the groundwork for examining the mac­
rophage. It soon became evident that macrophages in the resting state 
failed to generate appreciable quantities of either superoxide anion 
(0
2 




) (Johnston et al., 1981; Nathan and 
Root, 1977). However, when harvested from animals undergoing infec­
tion with Listeria or bacillus Calmette-Guerin they produced large 
amounts of both products. To examine this modulation in more detail, 
we chose the in vitro environment and the host-parasite interaction of 
Trypanosoma cruzi tryposmastigotes with resident murine peritoneal 
macrophages (Nogueira and Cohn, 1978). In the presence of usual 
media these organisms replicated free in the cytoplasm of the mac­
rophage, having lysed the endocytic vacuole shortly after ingestion 
(Nogueira and Cohn, 1976). After 72 hours the resulting amastigotes 
ruptured their hosts and initiated another cycle of infection. 
The addition of supernatants from specific antigen-triggered sen­
sitized T cells (lymphokines) lead to a dramatic increase in the ability of 
the macrophage to destroy the trypomastigotes (Nogueira and Cohn, 
1978). At concentrations as low as 2% and treatment from 24 hours in 
vitro, resident macrophages took on the structural properties of the 
activated mode and sterilized the intracellular milieu. Organisms ini­
tially free in the cytoplasm at the onset_ of lymphokine therapy were seen 
in various stages of degeneration within newly formed autophagic vac­
uoles. Subsequently, we extended this analysis to Toxoplasma and 
Leishmania with basically similar results (Murray et al., 1979). 
One could now correlate the formation of toxic oxygen intermediates 





and intracytoplasmic killing was established in acti­
vated cells of both the intact mouse and macrophages exposed to lym­
phokines in vitro (Nathan et al., 1979a,b,c). In addition, parasites 





were appropriately sensitive to this reagent. Monocytes rapidly 
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lose their endogenous supply of azurophil granule localized my­
eloperoxidase during maturation to the macrophage. Therefore, the mi­
crobicidal process of activated macrophages appears to depend largely 




is only one example. 
This is not to exclude other factors such as proteases, which may in fact 
operate through an oxygen-dependent mechanism (Johnston et al., 
1981). 
B. The Extracellular Milieu
Much of the hydrogen peroxide generated by activated macrophages 
is liberated into the extracellular milieu. Here depending upon local 
concentrations it can destroy sensitive eukaryotic targets including tu­
mor cells (Nathan et al., l 979a,b). As in the case of intracellular tar­
gets, toxic oxygen intermediates are responsible for much of the activity 
of macrophages against neoplastic cells. A number of studies have 
demonstrated the oxygen dependence of the process and its correlation 









secretion may be vectorial and limited to the membrane zone 
exposed to the inducing stimulus. Secretion may then occur within 
lacunae, separated from the general environment and reminiscent of the 
bone absorbing events carried out by osteoclasts. 
Both tumor cells and intracellular microbes demonstrate considerable 
variation in their sensitivity to oxygen intermediates (Nathan et al., 
1980a,b). With murine tumor cells this is best correlated with their 
content of scavengers of oxygen radicals and in particular with cellular 
levels of gluthathione (Arrick et al., 1982). Figure 4 illustrates some of 
the pathways implicated in the maintenance of reduced glutathione 
(GSH). Factors including oxygen per se and oxidizable substrates 
(glucose) influence GSH levels. Figure 4 includes more specific agents 
that inhibit synthesis (buthionine sulfoximine), GSH peroxidase (se­
lenium deficiency), GSSG reductase (BCNU) and shows electrophiles 
that complex GSH (CDNB + SLs). Each to a greater or lesser extent 
can sensitize tumor cells for an oxidative attack and may shift the dose­




by as much as 50- to 100-fold (Arrick et 
al., 1982). One may also kill tumor cells in the peritoneal cavity by 
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F10. 4. Pathways implicated in the maintenance of reduced glutathione (GSM). 
limiting reactant under these conditions is molecular oxygen, and tu­
mor-killing can be enhanced by exposing animals to a high p0
2
. Both 
the generation of local concentrations of toxic oxygen intermediates and 
the inhibition of tumor scavenging systems may well have a place in the 
therapeutic armamentarium of the future. 
VI. THE MACROPHAGE AS A MEDIA TOR OF INFLAMMATION 
The more classic view has considered the macrophage only in terms 
of chronic, granulomatous forms of inflammation. There is now rather 
compelling evidence that suggests important roles of macrophages in 
immediate forms of allergy as well. These include the presence of large, 
constant tissue pools and the production of potent metabolites that can 
influence the microvasculature and smooth muscle-containing struc­
tures. One of the more interesting concerns the metabolites of arach­
idonic acid (20:4), an unsaturated fatty acid present in macrophage 
membrane phospholipids at the high level of 25 mol % . Exposure of 
macrophages to particulate stimuli leads to the release of as much as 
60-70% of the total arachidonate as metabolites of both the cycloox-
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ygenase and lipoxygenase pathways (Scott et al., 1980). The products 
of mouse populations is outlined in Table III (Rouzer et al., 1980a, 
1982). It is apparent that large amounts are formed in response to 
immune complexes of IgG and IgE. Phagocytosis per se is not required; 
merely the interaction of a multivalent ligand with the Fe receptor on the 
cell surface is sufficient to trigger the secretory event (Rouzer et al., 
1980b). This is a new role for the Fe receptor in addition to its better 
TABLE III 
THE ARACHIDONATE METABOLITES OF MURINE MACROPHAGE POPULATIONS 
Amount 
Macrophage source Stimulus Product (pmol/ 107 cells) 
Resident peritoneal Zymosan PGE2 14,000 
6-Keto-PGF 1a 6,000 
HETEs 3,300 
Leukotriene C 4,500 
IgG immune complexes PGE2 5,400 
6-Keto-PGF Ia 13,000 
Leukotriene C 2,000 
IgE immune complexes PGE2 5,400 
6-Keto-PGF 1a 13,000 
Leukotriene C 2,000 
IgE immune complexes PGE2 4,800 
6-Keto-PGF Ia 8,200 
Leukotriene C 1,100 
C. parvum-elicited Zymosan PGE2 3,000 
peritoneal
6-Keto-PGF 1a 150 
TXB2 650 
HETEs 850 
Leukotriene C 95 
Interstitial pulmonary Zymosan PGE2 2,300 
6-Keto-PGF 1a 1,100 
TXB2 1,500 
HETEs 5,600 
Leukotriene C 3,800 
Unidentified 3,000 
a PGE, PGF 1a, prostaglandins, E 1 and F 1a; IgG, immunoglobulin G; HETE, 12 L­
hydroxy-5,8,10, 14-eicosatetranoic acid; TXB, thromboxane B. 
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known activity for initiating phagocytosis. A second point is that the 
process of activation leads to a marked depression in the production of 
arachidonate metabolites (Scott et al., 1982b). At present the mecha­
nisms that modulate the phospholipases-and therefore the release of 
membrane 20:4 as well as the metabolic enzymes responsible for the 
production of the active metabolites-are unclear. One can consider 
that such regulating events might well influence the overall inflamma­
tion process. 
Although specific membrane stimuli are required for the production 
of cyclooxygenase and lipoxygenase products from the esterified 20:4 
of phospholipids, free 20:4 can be extensively metabolized without a 
stimulus (Scott et al., 1982a,b). Large quantities of products are con­
tinually formed from the free fatty acid via what has been called the 
exogenous pathway. 
VII. MACROPHAGE AND CELL-MEDIATED IMMUNITY 
There is little doubt that macrophages are important effector cells in 
immune responses characterized by delayed forms of hypersensitivity, 
nor that their secretory products such as prostaglandin E
2 
may suppress 
the function of lymphoid cells (Nussenzweig et al., 1980). There is 
even some unanimity of opinion that they may on occasion support the 
growth of lymphoid cells in the artificial test tube environment. What is 
less clear is their role as ''processors'' or ''presenters'' of antigen for 
the stimulation of T cells. We suspect that in fact macrophages play 
rather minor roles in this process, their preeminence being usurped by 
an adherent cell type that for years has been hiding among the forest of 
macrophage ruffles. This is the dendritic cell, a novel character in 
immune responses, which has been so elegantly isolated and charac­
terized by Steinman and his colleagues (Steinman and Nussenzweig, 
1980). The dendritic cell constitutively expresses large amounts of Ia 
antigen on its surface and serves as the most potent stimulator of the 
allogeneic and syngeneic mixed lymphocyte reaction (MLR) and other 
forms of reactions that lead to T-cell replication and the formation of 
cytotoxic T cells. Monoclonal antibodies specific for dendritic cells and 
C' can destroy the cell in mixed spleen populations and subsequently 
ablate the MLR, whereas similar studies employing anti-monocyte 
monoclonals do not alter the allogeneic MLR. 
Studied initially in the mouse, an analogous cell type with similar 
MACROPHAGE-VERSATILE ELEMENT OF IN FLAM MA TION 79 
properties is present in the rat and in man as well. In the human species 
it is present in small numbers in the circulation and has been purified by 
Van Voorhis et al. (1982). It is clear that the dendritic cell, serving as a 
passenger leukocyte in transplant studies, will have a major impact on 
transplantation and in the control of graft rejection. As the reagents for 
its study become more readily available, immunologists will cease their 
practice of referring to "adherent" populations and begin to distinguish 
between members of the mononuclear phagocytes and the dendritic 
cells. 
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